SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001062993-18-002922
Filing Date
2018-07-16
Accepted
2018-07-13 20:53:19
Documents
2
Group Members
CTI LIFE SCIENCES FUND II, L.P.CTI LIFE SCIENCES FUND, L.P.CTI PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G form13g.htm SC 13G 46095
2 EXHIBIT 1 exhibit1.htm EX-1 4939
  Complete submission text file 0001062993-18-002922.txt   52713
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Subject) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89971 | Film No.: 18953433
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 PLACE VILLE - MARIE, SUITE 1050 MONTREAL A8 H3B 4S6
Business Address 1 PLACE VILLE - MARIE, SUITE 1050 MONTREAL A8 H3B 4S6 5147982333X229
CTI Partners II, L.P. (Filed by) CIK: 0001743924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G